Abdominal pain, cramps and nausea are not uncommon during the period, instead many women regularly experience menstrual cramps. In the future, a new drug from the United States could help to alleviate the symptoms with the help of cannabis. However, the drug has not yet been officially approved, and it also conflicts with most drug laws.
Almost every woman knows menstrual pain
Almost every woman has suffered from period pain during her period and not a few are affected by the unpleasant symptoms every month. The symptoms may vary, but usually it is cramp-like pelvic pain that radiates up to the back and is accompanied by discomfort, hypersensitivity and fatigue. Circulatory problems, nausea, diarrhea or headache often occur in the course of menstrual cramps.
Suppositories should alleviate symptoms within 20 minutes. But that could soon be over, because the US company Foria has now launched a product on the market that is supposed to eliminate the problems within a few minutes. But “Foria Relief” is not a conventional medicine. Instead, according to the manufacturer, the preparation contains 60 mg of tetrahydrocannabinol (THC) and 10 mg of cannabidiol (CBD), which are the two main cannabis active ingredients.
The THC is said to relieve pain and cramps during the rule, the cannabidiol helps to fight inflammation and is effective against nausea. The hashish product, which is based on cocoa butter, has a targeted effect, because "when used as a suppository, the active ingredients are released exactly where they are needed," according to the Foria manufacturers on their website.
Mittel has no official approval yet
Cannabis belongs to the hemp family, from which hashish and marijuana can be obtained. It has long been known that the plant not only acts as an intoxicant, but can also be used to treat symptoms of illness. However, since drugs containing these substances violate most drug laws, Foria Relief is currently only available in California and Colorado, as cannabis is legal here.
It is therefore questionable whether the product will also be approved in Europe. In addition, according to a report from the ‘Huffington Post’, Foria has not yet received approval from the American Medicines Agency (FDA) and should therefore not be used by experts until the efficacy and safety has been scientifically proven. “Every drug must be fully assessed in terms of risks and benefits before it can be classified as safe for use. I would be very concerned about women who are using this product before it has been fully evaluated, ”said Dr. Helen Webberley of Oxford Online Pharmacy told the online newspaper. (No)